This is nice collaborative work
Key takeaways:
➡️Combination Low T + ED in young men associated with increased risk of future development of T2D, CVD, and HTN
➡️Initiation of TRT therapy mitigated some of these risks
@SMSNA_ORG@yoursexmedjour@HMethodistUro@bcm_urology
Hi #MedTwitter#UroSoMe! I’m Christabel Egemba, current MS4 at @umiamimedicine applying to the #UrologyMatch2026!
I’m passionate about public health research and health education! In my free time, I love playing basketball⛹🏾♀️, creative writing ✍🏾, and all things film/TV📺!
Very grateful for the support and inspiration I've found through @SWIUorg SWIUdents. Excited to share our work to inform similar efforts in surgical specialties!
📢New in @UrolOncol!
Association of metabolic syndrome and chronic kidney disease with nonmuscle invasive bladder cancer recurrence and progression
Click to read the article now▶️ https://t.co/FuYBfVIy2P
It was exciting to see the breadth of urology research shared at #AUA25 including some of my collaborations! I love learning from leaders in this field! Also, always great meeting new and old friends and mentors. Looking forward to take part in #uromatch2026!!
Grateful for the opportunity to present our research at #AUA2025 under the mentorship of @KatherineAminMD. There was so much to learn from leaders in the field about female sexual dysfunction and PFDs, and I loved getting to know other likeminded future doctors!
Oh. My. God. Look. At. This. Data.
11 million women w recurrent uti.
If using vaginal estrogen
73% less MORTALITY
51% less SEPSIS
22% less hospitalizations
📉 the graphs don’t lie
@Dr_Elise_De should get a Nobel prize for this work
#AUA25@AshleyGWinter
Join us in congratulating @chadritchmd who is recognized by @AmerUrological#AUA in its 2025-2026 Leadership Program class! 👏👏 Dr. Ritch is 1 of 28 participants nationwide selected for this prestigious and long-standing initiative designed for urologists who have demonstrated leadership within organized medicine. #urology #leadership #academicmedicine #DSUI
Great news! The FDA updated testosterone product labels today. The TRAVERSE trial found no increased CV risk, so the boxed warning is planned to be removed! However, a blood pressure warning has been added after ABPM studies. Use remains limited to men with medical conditions causing low T.
Beyond proud of our amazing @dsui_miami_uro URPS research team representing at #ICS2024 in Madrid 🇪🇸! With EIGHT projects (4 podiums! 🤩), I brought two students, 1 research fellow @suyencvilchez and 1 resident @MaxToweMD! we repped the US 🇺🇸💪🏽
Excellent presentation @NCSAUA by @IUMedSchool student Jacob Good on our Men’s Health research on infection rates & penile implants with irrisept irrigation. ➡️No difference in infection rates between different implants ~415 IPPs
@IUuro@rustjacob @DrCharlaHoldren